Reimagining the Female of The Oresteia for the Chinese Operatic Stage
TheaComm, an E-Journal of Theater Arts Communication · 2025
DOI: 10.22191/theacomm/volume2/article6 ↗Kurz gefasst
Fachartikel in der Zeitschrift TheaComm, an E-Journal of Theater Arts Communication, 2025. Verfasst von Rongnyu Chen.
Abstract (Originalsprache)
From the perspective of the theory and practice of intercultural theater, this article explores the Ping opera Legend of Two Cities, the adaptation from the only extant ancient Greek trilogy Oresteia. The adaptation of ancient Greek tragedies in the form of traditional Chinese operas faces the dual difficulties which are transformations from ancient to modern times, and from the West to the East as well. The queen Kelüdai (Clytemnestra) in Legend of Two Cities is not only a termagant murdering her husband, but also a female figure with much complex emotional performances than the original. As a result, her appearance has enriched the images of royal females in the upper strata of power without losing their motherhood in Chinese operas. The adaptation of Legend of Two Cities has widely absorbed the strengths of Chinese and Greek theater with special focus on incorporating the operatic concept of “emotional ontology”. Intercultural operas have dual-orientational value and significance for both Western theatrical classics and Chinese operas, that is to enrich the performing aesthetics of characters on stage globally.
Zitieren
APA
Chen, R. (2025). Reimagining the Female of The Oresteia for the Chinese Operatic Stage. TheaComm, an E-Journal of Theater Arts Communication. https://doi.org/10.22191/theacomm/volume2/article6
Vancouver
Chen R. Reimagining the Female of The Oresteia for the Chinese Operatic Stage. TheaComm, an E-Journal of Theater Arts Communication. 2025. doi:10.22191/theacomm/volume2/article6
BibTeX
@article{Chen2025,
author = {Chen, Rongnyu},
title = {Reimagining the Female of The Oresteia for the Chinese Operatic Stage},
journal = {TheaComm, an E-Journal of Theater Arts Communication},
year = {2025},
doi = {10.22191/theacomm/volume2/article6}
}
EUVIMED